Influence of Low Intensity Laser Therapy treatment and severity of Diseugia in breast and prostate cancer patients treated with taxanes: trial randomized, triple-blind, placebo-controlled trial - LASER - Light Amplification by Stimulated Emission of Radiation LASER - Light Amplification by Stimulated Emission of Radiation

Escola Cearense de Oncologia0 个研究点开始时间: 2021年1月5日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients older than 18 years with stage II, III and IV cancer free of previous chemotherapy treatment undergoing first adjuvant or neoadjuvant treatment with protocols of drugs of the taxane class (paclitaxel (Taxol®) or docetaxel (Taxotere® ) Chemotherapy protocols may or may not be associated with other drugs.

•Patients with a history of radiotherapy in the head and neck, smokers, with anemia (hemoglobin less than 12 g / dl in women or 13 g / dl in men), untreated diabetes mellitus (from 200 mg / dL), using drugs that significantly alter the salivary flow, saliva composition, or taste (VRIES et al., 2018), in the use of central acting analgesics or anxiolytics and antidepressants. Patients who withdraw from treatment or study will be withdrawn from the study, requiring a change in the chemotherapy protocol with substitution of taxanes, discontinuing chemotherapy for any reason or developing systemic infections.

发起方

Escola Cearense de Oncologia